Roivant Sciences President, Immunovant CEO Eric Venker disposes of common shares worth $7.15 million

PUBT · 4d ago
Roivant Sciences President, Immunovant CEO Eric Venker disposes of common shares worth $7.15 million
  • Roivant Sciences President and Immunovant CEO Eric Venker cut his stake to 1,599,154 common shares on Aug. 28, 2026.
  • Disposed of 200,000 shares at prices of USD 35.63 and USD 36.44.
  • Exercised stock options for 200,000 shares at USD 3.85.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Roivant Sciences Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-26-035375), on September 01, 2026, and is solely responsible for the information contained therein.